![Quiver Logo](/static/img/logo-icon.png)
![QURE logo](https://quiver-logos.s3.us-east-2.amazonaws.com/qure.png)
uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view QURE Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Recent trades of QURE by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by QURE's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Recent insights relating to QURE
Recent picks made for QURE stock on CNBC
ETFs with the largest estimated holdings in QURE
Flights by private jets registered to QURE
![Quiver Logo](/static/img/logo-icon.png)